ACT TWO Trademark

Trademark Overview

On Wednesday, March 8, 2023, a trademark application was filed for ACT TWO with the United States Patent and Trademark Office. The USPTO has given the ACT TWO trademark a serial number of 97828379. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Thursday, June 11, 2026. This trademark is owned by Novast Laboratories, Inc.. The ACT TWO trademark is filed in the Pharmaceutical Products category with the following description:

emergency contraceptive tablets

General Information

Serial Number97828379
Word MarkACT TWO
Filing DateWednesday, March 8, 2023
Status734 - FIFTH EXTENSION - GRANTED
Status DateThursday, June 11, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 30, 2023

Trademark Statements

Goods and Servicesemergency contraceptive tablets

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovast Laboratories, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPlano, TX 75024
US
Party NameNovast Laboratories, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPlano, TX 75024
US

Trademark Events

Event DateEvent Description
Saturday, March 11, 2023NEW APPLICATION ENTERED
Monday, March 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 19, 2023ASSIGNED TO EXAMINER
Monday, April 24, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 10, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 30, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 30, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 23, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 23, 2024SOU EXTENSION 1 FILED
Tuesday, January 23, 2024SOU EXTENSION 1 GRANTED
Thursday, January 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 9, 2024SOU EXTENSION 2 FILED
Tuesday, July 9, 2024SOU EXTENSION 2 GRANTED
Tuesday, July 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 31, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, December 31, 2024SOU EXTENSION 3 FILED
Tuesday, December 31, 2024SOU EXTENSION 3 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 17, 2025SOU TEAS EXTENSION RECEIVED
Thursday, July 17, 2025SOU EXTENSION 4 FILED
Thursday, July 17, 2025SOU EXTENSION 4 GRANTED
Friday, July 18, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 19, 2026SOU TEAS EXTENSION RECEIVED
Wednesday, June 10, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, January 18, 2026SOU EXTENSION 5 FILED
Thursday, June 11, 2026SOU EXTENSION 5 GRANTED
Thursday, June 11, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

tablets contraceptive emergency